Home › Degenerative Nerve Diseases › New York › New York City
Degenerative Nerve Diseases clinical trials in New York City, NY
3 studies for Degenerative Nerve Diseases are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
RecruitingPhase 2
- Clinical Site, New York
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
RecruitingPhase 2
- Vima Site #024, New York
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
RecruitingObservational studyHealthy volunteers welcome
- Beth Israel Medical Center, New York
- NYU Langone Health, New York
About Degenerative Nerve Diseases
Neurodegenerative (degenerative nerve) diseases are disorders that destroy motor neurons. Parkinson's is an examples. See a list of all the diseases.
More about Degenerative Nerve Diseases on MedlinePlus
Degenerative Nerve Diseases trials in other cities
- Philadelphia, PA6 studies
- Orlando, FL5 studies
- Boston, MA5 studies
- Tampa, FL5 studies
- Atlanta, GA4 studies
- Scottsdale, AZ4 studies
- San Diego, CA4 studies
- Chicago, IL3 studies
- Gainesville, FL3 studies
- Boca Raton, FL3 studies
- Baltimore, MD3 studies
- San Francisco, CA3 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.